Source:http://linkedlifedata.com/resource/pubmed/id/12699057
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2003-4-17
|
| pubmed:abstractText |
Fine-needle aspiration cytology (FNAC) is essential for making a diagnosis in advanced breast cancer. The determination of hormone receptors in the material obtained is useful for predicting patient response to endocrine therapy, but the prognostic value of hormone receptor expression as well as the clinical utility of DNA flow cytometry are controversial. The aim of this prospective study with long-term follow-up (median: 81 months) was to evaluate these biomarkers in relation to overall survival in a series of 392 patients with advanced breast cancer (stage IIB, n=106; IIIA, n=66; IIIB, n=174; and IV, n=46) using FNAC. Estrogen and progesterone receptor expression was found in 65.1% and 46.1% of the tumors, respectively. Hormone receptors were not found to be associated with clinical staging. DNA aneuploidy was present in 70.9% of the cases and the median S-phase fraction (SPF) was 9.4%. There was a significant correlation of aneuploidy and high SPF with lack of hormone receptors. In univariate analysis, advanced disease stage, absence of hormone receptors, DNA aneuploidy and high SPF showed a statistically significant correlation with poor clinical outcome. In multivariate analysis, disease stage, progesterone receptors and DNA ploidy retained independent prognostic significance in relation to overall survival. These data indicate that progesterone receptor expression and DNA ploidy are independent prognostic factors in advanced breast cancer.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0393-6155
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
18
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
7-12
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:12699057-Adult,
pubmed-meshheading:12699057-Aged,
pubmed-meshheading:12699057-Aged, 80 and over,
pubmed-meshheading:12699057-Aneuploidy,
pubmed-meshheading:12699057-Biopsy, Needle,
pubmed-meshheading:12699057-Breast Neoplasms,
pubmed-meshheading:12699057-Female,
pubmed-meshheading:12699057-Flow Cytometry,
pubmed-meshheading:12699057-Follow-Up Studies,
pubmed-meshheading:12699057-Humans,
pubmed-meshheading:12699057-Middle Aged,
pubmed-meshheading:12699057-Multivariate Analysis,
pubmed-meshheading:12699057-Ploidies,
pubmed-meshheading:12699057-Prognosis,
pubmed-meshheading:12699057-Prospective Studies,
pubmed-meshheading:12699057-Receptors, Estrogen,
pubmed-meshheading:12699057-Receptors, Progesterone,
pubmed-meshheading:12699057-Time Factors
|
| pubmed:articleTitle |
Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients.
|
| pubmed:affiliation |
Department of Pathology, Portuguese Oncological Institute, Lisbon, Portugal. apat@ipolisboa.min-saude.pt
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|